{
  "zip": "L4B 3J9",
  "sector": "",
  "fullTimeEmployees": 10,
  "longBusinessSummary": "Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy to treat multiple myeloma, as well as a license agreements with Xisle Pharma Ventures Trust and National Research of Council Canada. The company is headquartered in Richmond Hill, Canada.",
  "city": "Richmond Hill",
  "phone": "905 841 2300",
  "state": "ON",
  "country": "Canada",
  "companyOfficers": [],
  "website": "http://www.helixbiopharma.com",
  "maxAge": 1,
  "address1": "9120 Leslie Street",
  "fax": "905 841 2244",
  "industry": "",
  "address2": "Suite 205",
  "previousClose": 0.7338,
  "regularMarketOpen": 0.6703,
  "twoHundredDayAverage": 0.35093525,
  "trailingAnnualDividendYield": null,
  "payoutRatio": null,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.6703,
  "navPrice": null,
  "averageDailyVolume10Day": 537,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.7338,
  "fiftyDayAverage": 0.33363637,
  "trailingAnnualDividendRate": null,
  "open": 0.6703,
  "averageVolume10days": 537,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.00462,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.6688,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 200,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 63189092,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 811,
  "priceToSalesTrailing12Months": null,
  "dayLow": 0.6688,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 200,
  "fiftyTwoWeekHigh": 1.15,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.22,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.6703,
  "exchange": "PNK",
  "shortName": "HELIX BIOPHARMA CORP",
  "longName": "Helix BioPharma Corp.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "HBPCF",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_876399",
  "uuid": "7e118b26-190e-3f30-be21-25587d45f294",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 102810000,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1596153600,
  "heldPercentInstitutions": 0.19832,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.1604,
  "nextFiscalYearEnd": 1659225600,
  "mostRecentQuarter": 1604102400,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 114717121,
  "enterpriseValue": 99160608,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.6703,
  "logo_url": "https://logo.clearbit.com/helixbiopharma.com"
}